RTW INVESTMENTS, LP
CIK 00014932159 SPACs with a current declared position, filed between Feb 26, 2020 and Nov 14, 2024. 0 of them were re-affirmed in the last 12 months. The rest are the filer’s last word on a position, not proof it is still held: an amendment is only required on a material change, so a fund that sells below 5% may never file again.
This filer has not filed a Schedule 13 on any SPAC since Nov 14, 2024. Read the page below as a record of what was declared, not as a register of what is held.
Filed under 1 earlier name
RTW INVESTMENTS, LLCEDGAR’s own former-name record for CIK 0001493215. The page did not move when the filer renamed, because the identity is the CIK and the URL is a label it owns.
Positions
one row per SPAC — every figure read from the accession in the Source column| SPAC | Voting | Dispositive | Source | |||||
|---|---|---|---|---|---|---|---|---|
| HSAQ | Health Sciences Acquisitions Corp 24 reporting persons on this schedule | 21.5% | 7,704,030 | 0 / 7,704,030 | 0 / 7,704,030 | Closed (deSPAC) | Aug 7, 2024Stale | SC 13D/A · may seek to influence control0001193125-24-196045 12 earlier statements |
| CHAQ | Chardan Healthcare Acquisition 2 Corp.3 reporting persons on this schedule | 11.1% | 1,525,476 | 0 / 1,525,476 | 0 / 1,525,476 | Closed (deSPAC) | Apr 5, 2023Stale | SC 13D/A · may seek to influence control0000902664-23-002480 9 earlier statements |
| BCYP | Big Cypress Acquisition Corp.2 reporting persons on this schedule | 10.0% | 9,220,672 | 0 / 9,220,672 | 0 / 9,220,672 | Closed (deSPAC) | Feb 14, 2024Stale | SC 13G0000902664-24-001535 |
| PCSC | Perceptive Capital Solutions Corp2 reporting persons on this schedule | 8.3% | 742,500 | 0 / 742,500 | 0 / 742,500 | Closed (deSPAC) | Nov 14, 2024Stale | SC 13G0000902664-24-006496 |
| PHGE | Chardan Healthcare Acquisition Corp.4 reporting persons on this schedule | 6.9% | 900,000 | 0 / 900,000 | 0 / 900,000 | Closed (deSPAC) | Feb 26, 2020Stale | SC 13G/A0001493152-20-002975 8 earlier statements |
| LSAQ | Lifesci Acquisition II Corp.3 reporting persons on this schedule | 6.7% | 3,975,000 | 0 / 3,975,000 | 0 / 3,975,000 | Closed (deSPAC) | Feb 14, 2022Stale | SC 13G/A0000902664-22-001626 4 earlier statements |
| HLXA | Helix Acquisition Corp2 reporting persons on this schedule | 6.3% | 750,000 | 0 / 750,000 | 0 / 750,000 | Closed (deSPAC) | Feb 16, 2021Stale | SC 13G0001493152-21-003868 |
| LSAC | LifeSci Acquisition Corp.3 reporting persons on this schedule | 5.4% | 750,000 | 0 / 750,000 | 0 / 750,000 | Closed (deSPAC) | Feb 14, 2022Stale | SC 13G/A0000902664-22-001625 1 earlier statement |
| IMVT | Health Sciences Acquisitions Corp3 reporting persons on this schedule | 0.0% | 0 | 0 / 0 | 0 / 0 | Closed (deSPAC) | Dec 5, 2022Stale | SC 13G/A0001193125-22-298431 6 earlier statements |
40 superseded statements (newest 15 shown)
An amendment replaces a stake as current; it never erases the record of it. These are the earlier statements, each with the accession that replaced it — kept because “what did this filer say in 2022” is a different question from “what does it say now”, and only the second one has an answer above.
- HSAQ Health Sciences Acquisitions Corp 215.7% · SC 13D/A May 5, 2023replaced Aug 7, 2024 by 0001193125-24-196045
- HSAQ Health Sciences Acquisitions Corp 216.2% · SC 13D/A Jan 27, 2023replaced May 5, 2023 by 0001493152-23-015516
- IMVT Health Sciences Acquisitions Corp6.5% · SC 13G/A Dec 2, 2022replaced Dec 5, 2022 by 0001193125-22-298431
- HSAQ Health Sciences Acquisitions Corp 28.9% · SC 13D Oct 12, 2022replaced Jan 27, 2023 by 0001493152-23-002808
- CHAQ Chardan Healthcare Acquisition 2 Corp.19.0% · SC 13D Sep 21, 2022replaced Apr 5, 2023 by 0000902664-23-002480
- CHAQ Chardan Healthcare Acquisition 2 Corp.17.0% · SC 13G/A Feb 14, 2022replaced Sep 21, 2022 by 0000902664-22-004311
- CHAQ Chardan Healthcare Acquisition 2 Corp.17.1% · SC 13G/A Sep 7, 2021replaced Feb 14, 2022 by 0000902664-22-001578
- CHAQ Chardan Healthcare Acquisition 2 Corp.12.9% · SC 13G Jul 29, 2021replaced Sep 7, 2021 by 0000919574-21-005729
- LSAQ Lifesci Acquisition II Corp.9.7% · SC 13G May 18, 2021replaced Feb 14, 2022 by 0000902664-22-001626
- LSAQ Lifesci Acquisition II Corp.6.6% · SC 13G Feb 16, 2021replaced May 18, 2021 by 0001493152-21-012130
- IMVT Health Sciences Acquisitions Corp7.8% · SC 13G/A Feb 16, 2021replaced Dec 2, 2022 by 0001193125-22-297531
- LSAC LifeSci Acquisition Corp.5.4% · SC 13G Feb 16, 2021replaced Feb 14, 2022 by 0000902664-22-001625
- PHGE Chardan Healthcare Acquisition Corp.3.9% · SC 13G/A Feb 14, 2020replaced Feb 26, 2020 by 0001493152-20-002975
- PHGE Chardan Healthcare Acquisition Corp.6.9% · SC 13G/A Feb 14, 2019replaced Feb 14, 2020 by 0001493152-20-002376
- PHGE Chardan Healthcare Acquisition Corp.6.9% · SC 13G Dec 21, 2018replaced Feb 14, 2019 by 0001493152-19-001947
Reporting persons on this filer's schedules
one filer, several names — collapsed once, shown in fullA joint Schedule 13 names every person who beneficially owns the shares — the management company, the funds it advises, the general partner and often the individual who controls all three. They report the same shares. Counting them separately would publish this filer’s footprint two or three times over, so they are counted once, under CIK 0001493215. This filer has named 7 of them across the schedules in the table above:
- R o der i c k W o ng
- R oderick W o n g
- RTW Innovation Master Fund
- RTW Investments
- RTW Master Fund
- Roderick Wong
- Roderick Wong, M.D
Appears alongside
other filers with a current declared position in the same SPACsCo-occurrence in the disclosure record, and nothing more. It is not evidence of a group, an agreement or acting in concert — filers who act as a group say so on the cover page and file a 13D. Two arbitrage funds above 5% in the same shell is the ordinary shape of this market. The second number restricts both sides to statements filed in the last 12 months, because a 2021 stake beside a 2026 one is two facts about two different years.
- CITADEL ADVISORS LLC3 SPACs · 0 fresh
- RA CAPITAL MANAGEMENT, L.P.3 SPACs · 0 fresh
- ADAGE CAPITAL PARTNERS GP, L.L.C.2 SPACs · 0 fresh
- BIOTECHNOLOGY VALUE FUND L P2 SPACs · 0 fresh
- BlackRock Inc.2 SPACs · 0 fresh
- BOOTHBAY FUND MANAGEMENT, LLC2 SPACs · 0 fresh
- COMMODORE CAPITAL LP2 SPACs · 0 fresh
- Flynn James E2 SPACs · 0 fresh
- FMR LLC2 SPACs · 0 fresh
- PRICE T ROWE ASSOCIATES INC /MD/2 SPACs · 0 fresh
- 683 Capital Management, LLC1 SPAC · 0 fresh
- ADAR1 Capital Management, LLC1 SPAC · 0 fresh
- Affinity Asset Advisors, LLC1 SPAC · 0 fresh
- Altium Capital Management LP1 SPAC · 0 fresh
- AMR Action Fund, L.P.1 SPAC · 0 fresh
- ARMISTICE CAPITAL, LLC1 SPAC · 0 fresh
- BANK OF AMERICA CORP /DE/1 SPAC · 0 fresh
- BASSO CAPITAL MANAGEMENT, L.P.1 SPAC · 0 fresh
- Big Cypress Holdings LLC1 SPAC · 0 fresh
- BlackRock, Inc.1 SPAC · 0 fresh
- Broadview Ventures I LLC1 SPAC · 0 fresh
- Burbank John Howard III1 SPAC · 0 fresh
- Byrd John C.1 SPAC · 0 fresh
- Centaurus Investments Ltd1 SPAC · 0 fresh
Every percentage above is the one printed on the cover page of the filing cited beside it — a percentage of the shares outstanding on that date. A SPAC’s float collapses at each redemption, so two of these percentages are percentages of two different companies and they do not add. Rows are one per SPAC: where a joint schedule names several reporting persons, the largest single figure is shown rather than their sum, because a manager and the funds it advises beneficially own the same shares. Nothing on this page is derived from a 13F, a vendor holdings file or a press release. See how this is built.